不合理抗菌药物联合使用的增加：是否需要临床判例？
The Rise of Irrational Antimicrobial Combinations: Need for Clinical Jurisprudence?
作者信息
Kundu Riddhi, Baronia Tanima, Sathe Prachee
机构信息
Department of Critical Care Medicine, Ruby Hall Clinic, Pune, Maharashtra, India.
出版信息
Indian J Crit Care Med. 2024 Jun;28(6):618-619. doi: 10.5005/jp-journals-10071-24718.
Abstract
Kundu R, Baronia T, Sathe P. The Rise of Irrational Antimicrobial Combinations: Need for Clinical Jurisprudence? Indian J Crit Care Med 2024;28(6):618-619.
摘要
昆杜 R、巴罗尼亚 T、萨特 P。不合理抗菌药物联合使用的增加：临床判例法的必要性？《印度危重症医学杂志》2024 年；28(6)：618 - 619。
相似文献
1
The Rise of Irrational Antimicrobial Combinations: Need for Clinical Jurisprudence?
Indian J Crit Care Med. 2024 Jun;28(6):618-619. doi: 10.5005/jp-journals-10071-24718.
2
Multidrug Resistance: The Growing Menace in PICU.
Indian J Crit Care Med. 2023 Jan;27(1):6-7. doi: 10.5005/jp-journals-10071-24394.
3
Management of CRE Infections: High Time for an RCT?
Indian J Crit Care Med. 2024 May;28(5):516-517. doi: 10.5005/jp-journals-10071-24646.
4
Empathy: An Essential Skill in the Intensive Care Units.
Indian J Crit Care Med. 2019 Sep;23(9):391. doi: 10.5005/jp-journals-10071-23230.
5
Antimicrobial Stewardship Program in Critical Care-Need of the Hour.
Indian J Crit Care Med. 2020 Sep;24(9):847-854. doi: 10.5005/jp-journals-10071-23557.
6
Approach to the Control of Antimicrobial Resistance: Are We Missing the Plot?
Indian J Crit Care Med. 2020 Oct;24(10):899-900. doi: 10.5005/jp-journals-10071-23626.
7
Necrotizing Soft Tissue Infections: More than What Meets the Eye.
Indian J Crit Care Med. 2022 Summer;26(4):411-413. doi: 10.5005/jp-journals-10071-24196.
8
Trendelenburg in Acute Respiratory Distress Syndrome: Should We Do More than Proning?
Indian J Crit Care Med. 2022 Aug;26(8):976-977. doi: 10.5005/jp-journals-10071-24275.
9
Parturient with Acute Abdomen.
Indian J Crit Care Med. 2021 Dec;25(Suppl 3):S223-S229. doi: 10.5005/jp-journals-10071-24013.
10
Study of Antimicrobial Utilization and Cost of Therapy in Medicine Intensive Care Unit of a Tertiary Care Hospital in Eastern India.
Indian J Crit Care Med. 2020 Oct;24(10):938-942. doi: 10.5005/jp-journals-10071-23552.
本文引用的文献
1
Takeaways from the Recarbrio Conundrum: Has the FDA Jumped the Gun?
Indian J Microbiol. 2023 Dec;63(4):702-703. doi: 10.1007/s12088-023-01105-5. Epub 2023 Oct 3.
2
Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.
Clin Infect Dis. 2023 Jul 18. doi: 10.1093/cid/ciad428.
3
Ceftazidime-avibactam with or without Aztreonam vs Polymyxin-based Combination Therapy for Carbapenem-resistant Enterobacteriaceae: A Retrospective Analysis.
Indian J Crit Care Med. 2023 Jun;27(6):444-450. doi: 10.5005/jp-journals-10071-24481.
4
New antimicrobial treatment options for severe Gram-negative infections.
Curr Opin Crit Care. 2022 Oct 1;28(5):522-533. doi: 10.1097/MCC.0000000000000968. Epub 2022 Aug 4.
5
A Comparative Sensitivity Study of "Ceftriaxone-Sulbactam-EDTA" and Various Antibiotics against Gram-negative Bacterial Isolates from Intensive Care Unit.
Indian J Crit Care Med. 2020 Dec;24(12):1213-1217. doi: 10.5005/jp-journals-10071-23573.
6
CSE (Ceftriaxone+ Sulbactam+ Disodium EDTA) Versus Meropenem for the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis: PLEA, a Double-Blind, Randomized Noninferiority Trial.
Open Forum Infect Dis. 2019 Oct 1;6(10). doi: 10.1093/ofid/ofz373.
7
Mechanisms of Polymyxin Resistance.
Adv Exp Med Biol. 2019;1145:55-71. doi: 10.1007/978-3-030-16373-0_5.
8
β-Lactams and β-Lactamase Inhibitors: An Overview.
Cold Spring Harb Perspect Med. 2016 Aug 1;6(8):a025247. doi: 10.1101/cshperspect.a025247.
Zotero 插件